US$ 21.41
glp-1 nmda Nature: Dual-active molecules targeting GLP-1R and receptors exhibit superior anti-obesity effects Frontiers | The agony and
Description
Robert Kushner: The answer is yes

Researchers are still learning if weight loss during and after treatment can help reduce the risk of breast cancer recurrence (when the cancer comes back) or other complications

Ferrannini E

Exercise in obesitythe role of technology in health services: can this approach work

Li J, Woodward M, Perkovic V et al (2020) Mediators of the effects of canagliflozin on heart failure in patients with type 2 diabetes

This tentative interaction was explored in a recently conducted randomized clinical trial of patients with AUD treated with the GLP-1R agonist exenatide (similar to Ex4)
